🔎 Trials Near Me

Utama › Leukemia-Limfoma Limfoblastik Sel-T Pendahulu › California

Kajian klinikal Leukemia-Limfoma Limfoblastik Sel-T Pendahulu di California

5 kajian untuk Leukemia-Limfoma Limfoblastik Sel-T Pendahulu sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

  • City of Hope, Duarte
  • Children's Hospital Los Angeles, Los Angeles
Mengambil pesertaFasa 2
6 Months · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06514794

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

  • Loma Linda University Children's Hospital, Loma Linda
  • University of California, Los Angeles
  • University of California, San Francisco
Mengambil pesertaFasa 1
Sehingga umur 39 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT04972942

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

  • Rady Children's Hospital, San Diego
Mengambil pesertaFasa 2
Umur 1 hingga 18 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06390319

A Registry for People With T-cell Lymphoma

  • City of Hope Cancer Center (Data collection only), Duarte
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only), San Diego
  • University of California San Francisco (Data collection only), San Francisco
  • dan 1 lagi
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 20 Mei 2026 · NCT05978141

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • City of Hope, Duarte
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Apr 2025 · NCT06462365

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.